Metacrine, Inc. (NASDAQ:MTCR) Sees Large Decline in Short Interest

Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 808,600 shares, a drop of 33.7% from the April 15th total of 1,220,000 shares. Based on an average trading volume of 1,730,000 shares, the short-interest […]

Related Keywords

United States ,America , ,York Mellon Corp ,Goldman Sachs Group Inc ,Zacks Investment Research ,Renaissance Technologies ,Metacrine Inc ,America Corp ,Nasdaq ,Get Rating ,New York Mellon Corp ,Sachs Group ,Metacrine ,Nasdaq Mtcr ,Mtcr ,Medical ,Stocks ,Options ,Put ,Call ,